Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Mazor Robotics Marks Time as It Waits to Be Acquired

By Brian Feroldi - Nov 12, 2018 at 9:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's financial statements took a big step back during the quarter, but all eyes are on the pending Medtronic buyout.

Mazor Robotics ( MZOR ) reported its third-quarter results on Nov. 6. There wasn't a lot of fanfare involved with the earnings release since the company is currently waiting for its takeover by Medtronic ( MDT -0.38% ) to close. The agreement to buy out Mazor for $1.64 billion, or $58.50 per share, is expected to be completed in the next few of months.

Mazor's sales and margins took a big step backward while the company's attention is focused on finalizing the agreement. What's more, the company booked a number of one-time expenses related to the deal. The combination caused its net loss to balloon.

Mazor Robotics Q3 results: The raw numbers

Metric

Q3 2018

Q3 2017

Year-Over-Year Change

Revenue

$10.1 million

$18.6 million

(46%)

GAAP net income

($16.9 million) 

($3.9 million)

N/A

GAAP earnings per share

($0.32)

($0.08)

N/A

Data source: Mazor Robotics. GAAP = Generally accepted accounting principles.

What happened with Mazor Robotics this quarter?

  • The huge fall in sales was caused by the double whammy of a lower number of system placements and lower pricing due to its distribution agreement with Medtronic. Revenue from consumables also declined 1% to $6.9 million.
  • The huge loss of sales leverage and lower pricing terms caused gross margin to decline 1,500 basis points to 47.3%.
  • Operating expenses grew 42% to $22.3 million. The huge jump was mostly attributable to the $10.8 million in extra costs related to the acquisition.
  • On a non-GAAP basis, net loss was $4.4 million, or $0.08 per share.
  • Cash balance at quarter end was $108 million. 
Businessmen looking over a contract.

Image source: Getty Images.

What management had to say

Management didn't hold a conference call with investors or offer up any commentary on the company's quarterly performance. However, the company did state that the Mazor X Stealth Edition system, which utilizes technology that was developed by both Medtronic and Mazor, received FDA clearance on Nov. 2. 

Looking forward

Mazor is scheduled to hold a shareholder meeting on Nov. 19, at which time a vote will take place to officially approve the merger. The odds of getting the thumbs-up look very favorable, considering that Medtronic already owns a sizable portion of Mazor's stock and both companies' boards of directors have already unanimously approved the transaction. 

If Mazor's shareholders approve the merger, then the deal is expected to close before the end of Medtronic's third fiscal quarter, which ends on Jan. 25, 2019.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Medtronic plc Stock Quote
Medtronic plc
MDT
$106.87 (-0.38%) $0.41
Mazor Robotics Ltd. Stock Quote
Mazor Robotics Ltd.
MZOR

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
624%
 
S&P 500 Returns
140%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/05/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.